Studies have suggested that GLP-1RAs may show promise for a host of conditions, from alcohol use disorder to Parkinson’s. But ...

Telehealth company Him & Hers Health is taking a very different approach to its Super Bowl ad this year - as its new ...

A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans a ...

Telehealth provider will make its big game debut as the semaglutide shortage continues to sustain the firm’s lower-priced ...

LOS ANGELES (KTLA) – With the devastating Palisades Fire still smoldering, Lisa Pelton and some of her neighbors in ...

The study published in Nature Medicine is unique in its scope, marking a milestone in the study of new-generation weight-loss drugs such as Ozempic, Wegovy and Mounjaro, which have already somewhat ...

List of drugs account for $41 billion in annual Medicare spending, the Biden administration said.

A modern-day renaissance man, jazz trumpeter and opera composer Terence Blanchard is an 8-time Grammy Award-winner whose film scores have earned him two Oscar nominations. “I’m ...

WASHINGTON (AP) — Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and ...

WHAT IT MEANS FOR PATIENTSThe potential for more aggressive price cuts would enable wider access to GLP-1 drugs - the same class of drugs as Ozempic and Wegovy - for people over the age of 65.

The U.S. government named 15 drugs that will be subject to the second round of price negotiations by Medicare, including Ozempic and Wegovy, the drugs at the center of the weight-loss craze.

The current list price for Ozempic is $968.52 per pen without insurance. While this drug can be expensive, Novo Nordisk offers a savings card for those with commercial or private insurance who are ...